Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Maria Rosaria A Muscatello, Antonio Bruno, Pasquale De Fazio, Cristina Segura-Garcia, Gianluca Pandolfo & Rocco Zoccali. (2014) Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine. Expert Opinion on Pharmacotherapy 15:16, pages 2329-2345.
Read now
Read now
Articles from other publishers (16)
Idaiane Batista Assunção-Leme, André Zugman, Luciana Monteiro de Moura, João Ricardo Sato, Cinthia Higuchi, Bruno Bertolucci Ortiz, Cristiano Noto, Vanessa Kiyomi Ota, Sintia Iole Belangero, Rodrigo A. Bressan, Nicolas A. Crossley, Andrea P. Jackowski & Ary Gadelha. (2020) Is treatment-resistant schizophrenia associated with distinct neurobiological callosal connectivity abnormalities?. CNS Spectrums 26:5, pages 545-549.
Crossref
Crossref
Xiao-Jie Shi, Fang-Cheng Fan, Hua Liu, Yang-Wen Ai, Qing-Shan Liu, Yu-Guo Jiao & Yong Cheng. (2021) Traditional Chinese Medicine Decoction Combined With Antipsychotic for Chronic Schizophrenia Treatment: A Systematic Review and Meta-analysis. Frontiers in Pharmacology 11.
Crossref
Crossref
Ali Metehan Caliskan, Munir Karaaslan, Ikbal Inanli, Sila Caliskan, Mehmet Arslan, Ismet Esra Cicek & Ibrahim Eren. (2020) The effects of adding long-acting injectable antipsychotic drugs to clozapine on relapse and hospitalization in patients with treatment-resistant schizophrenia: a mirror-image retrospective study. International Clinical Psychopharmacology 36:1, pages 30-33.
Crossref
Crossref
Akin Ojagbemi & Oye Gureje. (2020) The Potential Role of Traditional Medicine in the Management of Schizophrenia. Current Psychiatry Reports 22:12.
Crossref
Crossref
Candice E. Crocker & Philip G. Tibbo. (2018) Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia. Frontiers in Pharmacology 9.
Crossref
Crossref
Yan-Yan Wei, Wan-Fu Lin, Tian-Hong Zhang, Yun-Xiang Tang, Ji-Jun Wang & Mao-Feng Zhong. (2018) Effectiveness of Traditional Chinese Medicineas as an Adjunct Therapy for Refractory Schizophrenia: A Systematic Review and Meta Analysis. Scientific Reports 8:1.
Crossref
Crossref
Clare M. Eddy. (2018) Social cognition and self-other distinctions in neuropsychiatry: Insights from schizophrenia and Tourette syndrome. Progress in Neuro-Psychopharmacology and Biological Psychiatry 82, pages 69-85.
Crossref
Crossref
Sebastian Moeller, Neele Kalkwarf, Caroline Lücke, Diana Ortiz, Sonja Jahn, Christiane Först, Niclas Braun, Alexandra Philipsen & Helge H.O. Müller. (2017) Achieving stable remission with maintenance electroconvulsive therapy in a patient with treatment-resistant schizophrenia. Medicine 96:48, pages e8813.
Crossref
Crossref
Omaima I Abdel Hamid, Marwa G Ahmed, Hanan MA Hassaneine & Hayam E Rashed. (2017) Evaluation of the role of captopril on clozapine-induced cardiotoxicity and hematotoxicity in adult male albino rats. Toxicology Research and Application 1, pages 239784731769653.
Crossref
Crossref
Arthur T. Koga, John Strauss, Clement Zai, Gary Remington & Vincenzo De Luca. (2016) Genome-wide association analysis to predict optimal antipsychotic dosage in schizophrenia: a pilot study. Journal of Neural Transmission 123:3, pages 329-338.
Crossref
Crossref
Bonginkosi Chiliza, Laila Asmal, Sanja Kilian, Lebogang Phahladira & Robin Emsley. (2015) Rate and predictors of non-response to first-line antipsychotic treatment in first-episode schizophrenia. Human Psychopharmacology: Clinical and Experimental 30:3, pages 173-182.
Crossref
Crossref
Myoung Suk Seo, Elizabeth Scarr, Chi-Yu Lai & Brian Dean. (2014) Potential Molecular and Cellular Mechanism of Psychotropic Drugs. Clinical Psychopharmacology and Neuroscience 12:2, pages 94-110.
Crossref
Crossref
David Castle, Nicholas Keks, Richard Newton, Isaac Schweitzer, David Copolov, Nick Paoletti, Graham Burrows & John Tiller. (2013) Pharmacological approaches to the management of schizophrenia: 10 years on. Australasian Psychiatry 21:4, pages 329-334.
Crossref
Crossref
Mitsumasa Kurita, Terrell Holloway, Aintzane García-Bea, Alexey Kozlenkov, Allyson K Friedman, José L Moreno, Mitra Heshmati, Sam A Golden, Pamela J Kennedy, Nagahide Takahashi, David M Dietz, Giuseppe Mocci, Ane M Gabilondo, James Hanks, Adrienne Umali, Luis F Callado, Amelia L Gallitano, Rachael L Neve, Li Shen, Joseph D Buxbaum, Ming-Hu Han, Eric J Nestler, J Javier Meana, Scott J Russo & Javier González-Maeso. (2012) HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nature Neuroscience 15:9, pages 1245-1254.
Crossref
Crossref
Tian-Mei Si, Yun-shu Zhang, Liang Shu, Ke-Qing Li, Xie-He Liu, Qi-Yi Mei, Gao-Hua Wang, Pei-Shen Bai, Li-Ping Ji, Xian-Sheng Cheng, Cui Ma, Jian-Guo Shi, Hong-Yan Zhang, Hong Ma & Xin Yu. (2012) Use of Clozapine for the Treatment of Schizophrenia: Findings of the 2006 Research on the China Psychotropic Prescription Studies. Clinical Psychopharmacology and Neuroscience 10:2, pages 99-104.
Crossref
Crossref
Mohammed Shahid. 2012. Designing Multi-Target Drugs. Designing Multi-Target Drugs
14
31
.